Ph.D. Roni Mamluk - 16 May 2022 Form 4 Insider Report for Ayala Pharmaceuticals, Inc.

Role
President & CEO, Director
Signature
/s/ Roni Mamluk, Ph.D.
Issuer symbol
N/A
Transactions as of
16 May 2022
Net transactions value
$0
Form type
4
Filing time
16 May 2022, 16:10:19 UTC
Previous filing
05 Jan 2022
Next filing
23 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYLA Common Stock Award $0 +120,000 +83% $0.000000 265,345 16 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted common stock, which will vest quarterly over a period of three years from May 16, 2022.